|
|
|
Volumn 14, Issue 6 A, 1994, Pages 2363-2370
|
|
Pharmacologically-guided dose adjustment of busulfan in high-dose chemotherapy regimens: Rationale and pitfalls
|
|
Author keywords
Bone marrow transplantation; Busulfan; Dose adjustment; Pharmacology
|
|
Indexed keywords
ANTICONVULSIVE AGENT;
BENZODIAZEPINE DERIVATIVE;
BUSULFAN;
CYCLOPHOSPHAMIDE;
HLA ANTIGEN;
MELPHALAN;
THIOTEPA;
ALLOGENIC BONE MARROW TRANSPLANTATION;
AUTOLOGOUS BONE MARROW TRANSPLANTATION;
CANCER;
CENTRAL NERVOUS SYSTEM DISEASE;
CHRONOPHARMACOLOGY;
CIRCADIAN RHYTHM;
CLINICAL TRIAL;
CONFERENCE PAPER;
DOSE CALCULATION;
DRUG ABSORPTION;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG EFFICACY;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LIVER FUNCTION;
LIVER TOXICITY;
LIVER VEIN OBSTRUCTION;
MORBIDITY;
MORTALITY;
ORAL DRUG ADMINISTRATION;
PATHOPHYSIOLOGY;
PHARMACODYNAMICS;
PRIORITY JOURNAL;
ADMINISTRATION, ORAL;
AGE FACTORS;
BONE MARROW TRANSPLANTATION;
BUSULFAN;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
DRUG INTERACTIONS;
HUMAN;
INTESTINAL ABSORPTION;
SUPPORT, NON-U.S. GOV'T;
|
|
EID: 0028556958
PISSN: 02507005
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (49)
|
|
References (0)
|
